MedTrace Logo

Magnesium for Neonatal Neuroprotection and Mothers

NCT01482078 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-10-12

No results posted yet for this study

Summary

Magnesium is a treatment for mothers to protect brains of babies born early. This study investigates combined effects of magnesium and spinal or epidural anesthesia on mothers having cesareans.

The investigators will use a scoring system to measure sedation and devices that subjects breath in and out of to measure breathing strength.

The investigators hypothesize the combination of magnesium and anesthesia will reduce breathing strength and cause sedation.

This is an observational study comparing those having magnesium and anesthesia with those just having anesthesia. Routine medical care will not be altered.

Results will hopefully allow anesthesiologists to provide better patient care.

Conditions

  • Premature Birth
  • Sedation During Labor and Delivery; Complications, Pulmonary
  • Respiratory Depression

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • James Brown, MB BCh · BC Women's Hospital, University of British Columbia

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-26
Primary Completion
2019-07-31
Completion
2019-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01482078 on ClinicalTrials.gov